medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Johnson & Johnson Eyes Larger Pie of Orthopaedic Market

In a bid to grow its presence in the Indian orthopaedic devices market, US healthcare giant Johnson & Johnson (J&J) is planning to roll out India-specific devices. These new products are designed in India to specifically meet the lifestyle needs of Indian people and will have competitive pricing, sources said. For starters, J&J has recently rolled out a India-specific knee implant christened ‘PFC Sigma RP-F Knee’. “We do undertake new product development of medical devices in India such as PFC Sigma RP-F Knee. For the patient, this means that the device closely mimics the natural motion of a knee joint allowing them to perform activities like playing with children, kneeling down to pray or bending to cook,” said J&J India director Anil Nayak. Incidentally, J&J operates its orthopaedic devices business through DePuy Orthopaedics. In India, the company has products ranging from orthopaedic implants for hip, knee and shoulder replacement to high technology equipment for computer-navigated surgery.

The company has identified India as a key growth market for this business. “J&J intends to bring to the Indian market high technology products, train doctors to increase the specialist pool and empower patients by increasing awareness about disease conditions and its management,” said Mr Nayak. J&J is the market leader in the Indian joint replacement implant market. Industry sources said the overall domestic market is growing at nearly 25-30% with J&J outstripping this rate. According to a Frost & Sullivan study, the number of knee replacement surgeries in India is expected to rise to 39,000 by 2009 from around 25,000 procedures performed in 2007.

The company imports the orthopaedic products from Europe and US for the Indian operations and has no immediate plans to manufacture them here. “However, as India is one of the key markets, we do have a competitive pricing strategy for the region,” said Mr Nayak. DePuy, with a global turnover of $4.1 billion in 2006, is the largest contributor to J&J’s revenues from the medical devices and diagnostic segment at $20.2 billion. J&J had closed 2006 with worldwide sales of around $53.5 billion across all its businesses.

(Ref: The Econoics Times dated Janurary 6, 2008)

Pharma Industry Packaging Gets Innovative

Alu Alu is the new buzzword in pharma industry. The industry has hit upon an innovative packaging technique that not only keeps the products dry for a longer time, but also increased the shelf life of the product. An alu alu blister is a composite materials made out of Nylon, Aluminium and PVC. Nylon, is on the top, aluminium is in the middle and PVC is the bottom. All the three materials compressed to form a blister.

The packaging results in longer expiry date of the product and also prevents adulteration of the medicines. A major chunk of the alu-alu blister packaging is imported from Korea and China as there is only one player in India. Nearly, 60% of the supplies come from Korea, 35% from China and around 5% from India. In India, only Hindalco produces the alu-alu blister packaging. Korean products are preferred as the Chinese products have high incidence of rejection. The unique characters of this packaging is that it protects the drug from high degree of moisture, increase the shelve life of the drug, prevents duplication, avoid market rejection of drugs, protects from light. Chairman of RS Foils, Madhav Kajriwal told ET that the demand for alu alu blister gained ground amongst the Gujarat's pharma industry. He said that two more new forms of pharma packaging would be introduced shortly in Gujarat by various players. They are tropical foil and child foil, which are similar to alu-alu blister but much higher in quality. The alu alu material was researched and developed by Alcon (Aluminium Company of America). Already 50% of the pharma companies based in Uttarakhand and Baddi are using the new packaging. In Gujarat Torrent Pharma, Cadila Pharma and Intas are the major users. Cadila Pharmaceutical has 10-12 products, while Torrent Pharma has 37 products packed in alu-alu blisters. As per Torrent Pharma spokesperson, an alu-alu packaging is almost 4 times costlier than the conventional ones. AJ Thakker says that in the long run, there is an indirect benefit for the company.

(Ref : The Times of India dated January 22, 2008)


Next
 

Other News

India To Emerge Leading Pharma Market Of The World
SMEs Applying For CE Tag On Products May Get Govt Aid
Asian Healthcare Sector To Beat US
IIM-A To Attract Healthcare Innovations
Johnson & Johnson Eyes Larger Pie of Orthopaedic Market
Pharma Industry Packaging Gets Innovative

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next